Evidence map›Paper›PMID 36781608›Full record

ArticleMolecular biology reports2023

The SOCS-1 -1478CA/del functional polymorphism (rs33989964) is associated with gastric cancer but is unrelated to overall survival.

Mustafa Hartavi, Omer Fatih Olmez, Barbaros Oral, Erdem Cubukcu, Selim Giray Nak

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mustafa HartaviDepartment of Internal Medicine, Faculty of Medicine, Uludag University, 16059, Bursa, Turkey. hartavimustafa@gmail.com.ORCID http://orcid.org/0000-0002-1922-742X
Omer Fatih OlmezDepartment of Medical Oncology, Faculty of Medicine, Uludag University, Bursa, Turkey.
Barbaros OralDepartment of Immunology, Faculty of Medicine, Uludag University, Bursa, Turkey.
Erdem CubukcuDepartment of Medical Oncology, Faculty of Medicine, Uludag University, Bursa, Turkey.
Selim Giray NakDepartment of Gastroenterology, Faculty of Medicine, Uludag University, Bursa, Turkey.
Bursa Uludağ Üni̇versi̇tesi̇ · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn vitro studies have shown that the functional - 1478CA > del polymorphism (rs33989964) of the suppressor of cytokine signaling (SOCS)-1 gene is associated with an altered trascriptional activity. Here, we sought to examine the potential association of this polymorphism with the risk of gastric cancer (GC) and to analyze its prognostic impact on overall survival (OS). MATERIALS AND

methodsThe study cohort consisted of 74 Turkish patients with GC and 52 healthy controls. Genotyping of the SOCS-1 -1478CA > del polymorphism was carried out using restriction fragment length polymorphism analysis.

resultsAfter allowance of age and sex, multivariable logistic regression analysis revealed that the carriage of the del allele of the SOCS-1 -1478CA > del polymorphism was independently associated with an increased risk of GC (odds ratio = 6.78, 95% confidence interval = 3.24-10.99, P < 0.001). Kaplan-Meier analysis revealed no significant differences in OS for patients harboring at least one del allele of rs33989964 compared with CA/CA homozygotes (log-rank test, P = 0.17).

conclusionWhile the SOCS-1 -1478CA > del polymorphism is significantly associated with the risk of GC in the Turkish population, it does not affect OS.

Indexed as

Stomach NeoplasmsAllelesCase-Control StudiesGenetic Predisposition to DiseaseGenotypeHomozygoteHumansPolymorphism, GeneticSuppressor of Cytokine Signaling ProteinsSuppressor of Cytokine Signaling ProteinsAssociation studyGastric cancerPolymorphismSuppressor of cytokine signalingSurvival

Identifiers

PMID36781608
OpenAlexW4320482942

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.